These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

631 related articles for article (PubMed ID: 28479486)

  • 21. Classification of idiopathic inflammatory myopathies: pathology perspectives.
    Tanboon J; Nishino I
    Curr Opin Neurol; 2019 Oct; 32(5):704-714. PubMed ID: 31369423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Inflammatory myopathies: diagnosis and classifications].
    Dimitri D
    Presse Med; 2009; 38(7-8):1141-63. PubMed ID: 19282137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statins and myotoxic effects associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: an observational study in Japan.
    Watanabe Y; Suzuki S; Nishimura H; Murata KY; Kurashige T; Ikawa M; Asahi M; Konishi H; Mitsuma S; Kawabata S; Suzuki N; Nishino I
    Medicine (Baltimore); 2015 Jan; 94(4):e416. PubMed ID: 25634171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoantibodies in idiopathic inflammatory myopathies: Clinical associations and laboratory evaluation by mono- and multispecific immunoassays.
    Damoiseaux J; Vulsteke JB; Tseng CW; Platteel ACM; Piette Y; Shovman O; Bonroy C; Hamann D; De Langhe E; Musset L; Chen YH; Shoenfeld Y; Allenbach Y; Bossuyt X
    Autoimmun Rev; 2019 Mar; 18(3):293-305. PubMed ID: 30639643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review.
    Mahler M; Miller FW; Fritzler MJ
    Autoimmun Rev; 2014; 13(4-5):367-71. PubMed ID: 24424190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and histological findings associated with autoantibodies detected by RNA immunoprecipitation in inflammatory myopathies.
    Suzuki S; Yonekawa T; Kuwana M; Hayashi YK; Okazaki Y; Kawaguchi Y; Suzuki N; Nishino I
    J Neuroimmunol; 2014 Sep; 274(1-2):202-8. PubMed ID: 25064497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome.
    Lega JC; Fabien N; Reynaud Q; Durieu I; Durupt S; Dutertre M; Cordier JF; Cottin V
    Autoimmun Rev; 2014 Sep; 13(9):883-91. PubMed ID: 24704867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Idiopathic inflammatory myopathies from the viewpoint of a neurologist].
    Shimizu J
    Brain Nerve; 2013 Nov; 65(11):1269-74. PubMed ID: 24200604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Classification of idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific antibodies].
    Zheng S; Chen S; Wu L; Zhao D; Chen F; Zhu J; Li J
    Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jul; 40(7):1029-1035. PubMed ID: 32895158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory muscle disease - An update.
    Baig S; Paik JJ
    Best Pract Res Clin Rheumatol; 2020 Feb; 34(1):101484. PubMed ID: 32046904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune Mediated Necrotizing Myopathy: Where do we Stand?
    Mohammed AGA; Gcelu A; Moosajee F; Botha S; Kalla AA
    Curr Rheumatol Rev; 2019; 15(1):23-26. PubMed ID: 29623846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Murine models of idiopathic inflammatory myopathies.
    Okiyama N; Konishi R; Ichimura Y
    J Dermatol; 2024 Jul; 51(7):914-919. PubMed ID: 38321631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paraneoplastic myopathies.
    Mammen AL
    Handb Clin Neurol; 2024; 200():327-332. PubMed ID: 38494286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Myositis-specific autoantibodies].
    Gran JT; Molberg Ø; Dobloug GC; Andersson H; Taraldsrud E; Scheie D
    Tidsskr Nor Laegeforen; 2009 Aug; 129(16):1631-4. PubMed ID: 19721478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Classification, diagnosis, and management of idiopathic inflammatory myopathies.
    Lazarou IN; Guerne PA
    J Rheumatol; 2013 May; 40(5):550-64. PubMed ID: 23504386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and pathological features of immune-mediated necrotising myopathies in a single-centre muscle biopsy cohort.
    Yang H; Tian X; Zhang L; Li W; Liu Q; Jiang W; Peng Q; Wang G; Lu X
    BMC Musculoskelet Disord; 2022 May; 23(1):425. PubMed ID: 35524238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune-Mediated Necrotizing Myopathy.
    Pinal-Fernandez I; Casal-Dominguez M; Mammen AL
    Curr Rheumatol Rep; 2018 Mar; 20(4):21. PubMed ID: 29582188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Where are we moving in the classification of idiopathic inflammatory myopathies?
    Tanboon J; Uruha A; Stenzel W; Nishino I
    Curr Opin Neurol; 2020 Oct; 33(5):590-603. PubMed ID: 32852298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoantibodies in polymyositis.
    Targoff IN
    Rheum Dis Clin North Am; 1992 May; 18(2):455-82. PubMed ID: 1378227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis and classification of idiopathic inflammatory myopathies.
    Lundberg IE; Miller FW; Tjärnlund A; Bottai M
    J Intern Med; 2016 Jul; 280(1):39-51. PubMed ID: 27320359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.